NICE Ltd. NICE
Nasdaq · XNAS · stock · Services-Prepackaged Software
Chart by TradingView
6/9
Piotroski F — financial health
6.91
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.9B | $612.1M | $2.0B | $697.6M | $3.9B |
| 2024 | $2.7B | $439.5M | $1.8B | $797.7M | $3.6B |
| 2023 | $2.4B | $336.5M | $1.6B | $532.2M | $3.4B |
| 2022 | $2.2B | $265.1M | $1.5B | $447.8M | $3.1B |
| 2021 | $1.9B | $199.6M | $1.3B | $437.0M | $2.8B |
| 2020 | $1.6B | $196.7M | $1.1B | $456.1M | $2.6B |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.91 (safe)
- Working capital / assets 0.096
- Retained earnings / assets 0.649
- EBIT / assets 0.126
- Equity / liabilities 3.153
Source: SEC EDGAR filings · CIK 0001003935 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.